Health Care

Manufacturers have been eager to help those affected by the humanitarian crisis in Ukraine, with many even lending a hand on the ground.

What manufacturers have been doing: They’ve raised millions of dollars through their own charities and funding vehicles, donated parts of their own profits, provided free legal support and phone calls to Ukraine, given medications and food, coordinated the shipping of relief supplies and more.

• Some manufacturers with operations in Ukraine have helped employees and their families flee the country and find temporary homes elsewhere in Europe.

Shared values: “Manufacturers have a proud history of standing firm in support of democracy, and we stand with the Ukrainian people,” NAM President and CEO Jay Timmons said recently, following the unanimous vote by the NAM Board of Directors to denounce Russia’s invasion of Ukraine.

Partnering to help: To help the people of Ukraine, the NAM’s Emergency Response Committee has partnered with Project HOPE and is engaging with other members who are donating through this and other channels.

• These efforts are providing channels for manufacturers to support efforts on the ground. For example, advanced materials manufacturer Greene Tweed recently donated $25,000 through the NAM–Project HOPE partnership.
• Project HOPE, an international health care and disaster relief organization, has emergency response teams in both Ukraine and neighboring countries that are giving health and humanitarian assistance to refugees and internally displaced persons.
• The ERC is a volunteer-led group that works to provide resources and information to manufacturing leaders before, during and after crises, both domestic and international. In addition to its partnership with Project HOPE, the ERC is also working with domestic partner Good360 on Ukraine relief.

The NAM says: “Manufacturers are truly at the forefront of aid efforts to Ukraine,” said NAM Senior Director of International Trade and Regulatory Affairs Ryan Ong. “Collectively, they’ve raised tens of millions of dollars for food, shelter, medicine, health care and more for the people of Ukraine. They’ve stepped up to help those in need, just as they do as a group in any time of crisis or hardship.”

Those wishing to donate to Project HOPE can do so here. To get more information about NAM efforts or share what your company is doing, contact the ERC at [email protected].

Scottsdale, AZ –– The National Association of Manufacturers today honored NAM board member and Nephron Pharmaceuticals CEO and Owner Lou Kennedy with the Manufacturing Icon Award during the NAM’s spring board meeting in Scottsdale, Arizona. The award recognizes leaders who inspire Americans to promote, perpetuate and preserve manufacturing in America.

“Lou Kennedy embodies the spirit of manufacturing, possessing a fearless commitment to solving some of our nation’s and the world’s most pressing challenges,” said NAM President and CEO Jay Timmons. “With trademark enthusiasm, Lou inspires those around her and brings together people from all sorts of backgrounds around a common purpose. In channeling her drive and dedication toward the NAM and The Manufacturing Institute’s Creators Wanted campaign, she is changing lives not just in South Carolina but across America. Her support has been game changing, and her passion for building the manufacturing workforce has helped us see our own vision for Creators Wanted more clearly. We’re honored to present this award to Lou in recognition of her exceptional leadership.”

Kennedy serves as co-chair of Creators Wanted. Last year, Nephron Pharmaceuticals hosted the Creators Wanted Tour Live in West Columbia, South Carolina.

The NAM and the MI’s “Creators Wanted” campaign is a member-driven initiative to inspire, educate and empower more Americans to pursue careers in modern manufacturing and to shift perceptions about careers in the industry. The campaign supports MI initiatives for students, women, veterans and other underrepresented communities and features a first-of-its-kind mobile experience and tour. It seeks to cut the skills gap by 600,000 workers by 2025 and increase the number of students enrolling in technical schools, vocational schools and apprenticeships by 25%. The campaign also seeks to increase the percentage of parents who would encourage their children to pursue a career in modern manufacturing to 50% from 27%.

In 2019, Kennedy was named a STEP Ahead Award Honoree. The MI’s STEP Ahead Awards honor women in science, technology, engineering and production careers who have demonstrated excellence and leadership across all levels of the manufacturing industry. Kennedy continues to work with the MI to help increase women’s representation in manufacturing and support the next generation of female talent.

-NAM-

The National Association of Manufacturers is the largest manufacturing association in the United States, representing small and large manufacturers in every industrial sector and in all 50 states. Manufacturing employs more than 12.5 million men and women, contributes $2.57 trillion to the U.S. economy annually and has the largest economic multiplier of any major sector and accounts for 58% of private-sector research and development. The NAM is the powerful voice of the manufacturing community and the leading advocate for a policy agenda that helps manufacturers compete in the global economy and create jobs across the United States. For more information about the NAM or to follow us on Twitter and Facebook, please visit www.nam.org.

Michaela Almgren already has two jobs, but in recent months, she’s found herself appointed to a third: COVID-19-vaccine information hub.

A foot in each world: A pharmacist by training, Almgren divides her time between the University of South Carolina’s College of Pharmacy, where she is an assistant professor in the Department of Clinical Pharmacy and Outcomes Sciences, and Nephron Pharmaceuticals, where she is clinical adviser and pharmacy student internship director.

• Owing to her impressive background in drug formulation and analytical method development as a hospital pharmacist, as well as her skills as a lecturer, Almgren has also become a sort of de facto conspiracy-theory debunker when it comes to COVID-19 vaccination.

A go-to for facts: In recent months, in her capacity as both a professor and a Nephron employee, Almgren has given lectures and presentations about COVID-19, its variants and the vaccines—and she’s had significant follow-up questions from audience members. So many, in fact, that colleagues and others she has met teaching and at manufacturing gatherings have come to see her as a voice of reason capable of cutting through the noise.

• “A lot of people just fall into this misinformation mill” about the vaccine, Almgren said. “Typing in something like ‘Dangerous COVID-19 vaccine’ will give you this feed of articles, but it doesn’t mean the vaccine is dangerous.… That’s just how these [search engines] work.”

Convincing and calm: Almgren has been the impetus for the vaccination of several employees at Nephron, which has a 100% vaccination rate.

• “They’d say, ‘Thank you for talking with me. I was unsure about the vaccine, and it made me nervous, but talking with you made me feel that it was OK.’”

Fact vs. fiction: Almgren shared some of the top vaccine-related myths she’s successfully debunked during presentations and other conversations.

• “They have long-term side effects.” Fact: “This is where I talk about how these [vaccine] components don’t stay in your body more than 72 hours. The idea is just to elicit an immune response, and then it’s gone. And think about it on a global scale. If it was so deadly and terrible, by now we would see millions of people dropping dead or getting really sick” as a direct result.
• “They were rushed to market.” Fact: “When you actually look at how the clinical trial was defined, it was very similar to any other clinical trials for other vaccines. No shortcuts were taken. They just compressed the studies and ran them simultaneously.”
• “They’re not safe for kids.” Fact: “As a parent, I can totally understand why people would be concerned” about the vaccine for children, Almgren said. “But the clinical trial is out there, released and published in terms of how Pfizer did it. The data is clear showing the efficacy is there, and the side effects are minimal. If you have no issue with the polio vaccine or the tetanus shot, why is COVID-19 any different?”
• “Natural immunity is better.” Fact: “Natural immunity can be further boosted with the vaccine, and it wanes more than vaccine-induced immunity,” Almgren said. People who have had COVID-19 and get vaccinated “have an even stronger [immune] response.”

The last word: Check out the NAM and The Manufacturing Institute’s This Is Our Shot initiative to find out how you can protect yourself and the people you care about from COVID-19.

The Supreme Court is reviewing state and business led efforts to block two of President Biden’s signature vaccine mandate policies according to The Washington Post.

The policies: “One measure requires large private companies to implement a requirement for employees to either be vaccinated for COVID-19 or mask and be tested weekly. The second applies to health-care workers at facilities that receive certain federal funding. Together, the cases test a signature aspect of the White House’s response to the pandemic that has killed more than 800,000 people in the United States.”

The challenges: All of the court action on the cases so far has revolved around whether the rules should be stayed while the courts review the legality of the rules.  Lower courts have been divided over the policies. After the administration announced the rule for private companies, the U.S. Court of Appeals for the 5th Circuit blocked its enforcement. Shortly after that, A panel of the U.S. Court of Appeals for the 6th Circuit lifted the stay, and said the rules could go into effect. A similar split occurred around the healthcare mandate, with one court saying the rules could go forward and another court blocking them.

The Supreme issue: According to NAM Senior Vice President and General Counsel Linda Kelly, while the Supreme Court is considering only whether the policies should be stayed or allowed to go into effect while lower courts hear legal challenges to the provisions, the arguments covered several pivotal issues that go to the underlying merits of the challengers’ case.  Throughout the two-hour oral argument, the Justices and advocates sparred over whether federal agencies (v. Congress or the States) have the authority to impose the mandates, whether the mandates are overbroad and should instead target only certain high-risk workplaces, the extent to which vaccines are “necessary” (i.e., whether other mitigation measures would adequately protect workers), and whether the pandemic constitutes an emergency allowing the government to bypass notice and comment rulemaking. We expect the Court to issue a decision within the next few days.

Get vaxxed: Getting vaccinated is still important in order to protect yourself and the people around you. Check out the This Is Our Shot – a collaboration between NAM and The Manufacturing Institute – for tools and information.

Washington, D.C. – Following President Biden’s speech on new measures to combat COVID-19, National Association of Manufacturers President and CEO Jay Timmons released this statement:

“Americans can be grateful to President Trump for ‘Operation Warp Speed’ that enabled the United States to develop the lifesaving vaccines against COVID-19 and to President Biden for his continued focus on getting Americans vaccinated. We share their steadfast focus, and manufacturers have led the way in promoting the lifesaving COVID-19 vaccines. They are safe and effective vaccines made for us, by people like us—manufacturers in America.

“We look forward to working with the administration to ensure any vaccine requirements are structured in a way that does not negatively impact the operations of manufacturers that have been leading through the pandemic to keep Americans safe. It is important that undue compliance costs do not burden manufacturers, large and small alike.

“Getting all eligible Americans vaccinated will, first and foremost, reduce hospitalizations and save lives. But it is also an economic imperative in that our recovery and quality of life depend on our ability to end this pandemic. This is why the NAM and The Manufacturing Institute continue equipping manufacturers of all sizes with resources to promote vaccination through our ‘This Is Our Shot’ project.”

-NAM-

The National Association of Manufacturers is the largest manufacturing association in the United States, representing small and large manufacturers in every industrial sector and in all 50 states. Manufacturing employs more than 12.3 million men and women, contributes $2.35 trillion to the U.S. economy annually and has the largest economic multiplier of any major sector and accounts for 58% of private-sector research and development. The NAM is the powerful voice of the manufacturing community and the leading advocate for a policy agenda that helps manufacturers compete in the global economy and create jobs across the United States. For more information about the NAM or to follow us on Twitter and Facebook, please visit www.nam.org

Washington, D.C. – After the publication today of the National Association of Manufacturers’ latest report, “Ensuring a Healthy Future: The Impact and Importance of Pharmaceutical Manufacturing,” NAM President and CEO Jay Timmons released the following statement:

“Pharmaceutical manufacturers are essential to America’s health and well-being and to the success of our economy. They have helped lead our country through crisis, fight the pandemic and drive our recovery. The sector creates hundreds of thousands of jobs, and the work its quarter of a million employees perform is literally lifesaving, improving society in ways that are almost impossible to overstate.”

The report finds that not only have pharmaceutical manufacturers been pioneers in improving the human condition, but the industry also fuels other sectors of the economy.

According to the report:

• Pharmaceutical and medicine manufacturing directly employs an estimated 267,000 workers in the United States and supports nearly 1.9 million more jobs across the country.
• One job in the industry helps support six other jobs in the overall workforce.
• Pharmaceutical and medicine manufacturing generates nearly $339 billion in output. Further, $1.00 in pharmaceutical and medicine manufacturing output generates $1.09 in output elsewhere in the economy.
• For every $1.00 earned by an employee within the industry, $2.42 is earned by others elsewhere in the economy.

“The American public and policymakers too often overlook these accomplishments,” Timmons added. “Traditional economic analysis ignores the way this industry extends and enriches lives, and the public is not fully aware of pharmaceutical manufacturers’ constant focus on innovation and improving the quality of life for everyone. Pharmaceutical manufacturers are always researching, discovering and developing new medicines and treatments, operating at the core of our modern health care system. Their products make it possible for medical professionals to introduce and manage innovative new therapies, and of course, these manufacturers helped create lifesaving COVID-19 vaccines. Moreover, the industry has high economic multipliers that drive production and job creation in other industries.”

Additional Key Findings:

• A successful pharmaceutical ecosystem requires strong private-sector investment. 
  • In 2019, American pharmaceutical companies invested more than $83 billion in research and development, topping off nearly $1 trillion in R&D investment over the past 20 years. A recent study from the National Science Foundation’s National Center for Science and Engineering Statistics estimates that the pharmaceutical and medicine manufacturing sector alone accounts for roughly 17% of total R&D investment in the United States.
  • The pharmaceutical industry invests nearly 11.4% of its sales back into R&D. Indeed, the U.S. pharmaceutical industry invests on average roughly three times more in R&D as a percentage of sales than all other manufacturing industries.
• The industry creates valuable STEM jobs.
  • While roughly 6.7% of the U.S. workforce has a STEM occupation, 29.9% of all jobs in pharmaceutical and medicine manufacturing are STEM related. The pharmaceutical manufacturing sector employs more than four times the percentage of STEM workers employed in the overall workforce.
• Industry employees are highly productive.
  • Industry employees produce $1.3 million in output per employee. This is nearly seven times greater than the U.S. economy’s average output per employee ($188,000).

-NAM-

The National Association of Manufacturers is the largest manufacturing association in the United States, representing small and large manufacturers in every industrial sector and in all 50 states. Manufacturing employs more than 12.4 million men and women, contributes $2.44 trillion to the U.S. economy annually and has the largest economic multiplier of any major sector and accounts for 58% of private-sector research and development. The NAM is the powerful voice of the manufacturing community and the leading advocate for a policy agenda that helps manufacturers compete in the global economy and create jobs across the United States. For more information about the NAM or to follow us on Twitter and Facebook, please visit www.nam.org.

Watch Jay Timmons on CNBC

Timmons on Labor Shortages, Creators Wanted Campaign

“Let’s be upfront about it. We have a very severe worker shortage in our country right now. It’s why the NAM has been so focused on our Creators Wanted campaign, to attract that next generation of manufacturing workers, and we are in competition now all across every sector for workers.

…

“So, if you think about supply chain shortages, why is that happening? Part of it certainly is the pandemic and the ability for trade to move freely, but you also have issues of not enough people at factories producing the component parts that go into finished products. What does that lead to? That leads to higher prices. So, it’s a supply and demand issue. Jim Cramer earlier today talked about a focus on getting this worker shortage under control. He mentioned, for instance, one possibility of helping to deal with this is immigration reform and that he thinks that there is a potential bipartisan solution to that. I believe there is as well. We have been pushing that through our program called A Way Forward at the NAM for a number of years. We think that’s one thing that will help get the economy back and deal with some of these issues.”

Timmons on Separating Infrastructure Investment from the Budget Resolution

“I think it was an extraordinary achievement by the Senate, a bipartisan achievement by Republicans and Democrats to get that bill across the line. We said at the NAM from the start that we would see probably about $1.2 trillion without punishing and archaic tax increases that would take us back to a time when we weren’t able to invest and hire and grow wages like we have for the last three years…We think that this bipartisan solution needs to get across the finish line. This is a very big priority not only for the president, but also for the American people. We know that can get done.

“…the reconciliation package that may be being developed…we have some serious concerns. We will certainly oppose any of the archaic tax increases that have been discussed. We are hearing somewhere between $1.8 and $3.5 trillion on job creators in America. That would take us to where we were before the 2017 tax reforms, where, afterwards, as I said, we were able to have record investment, record job creation, record wage growth. Why would we ever want to undo that? We are watching that very closely. We will oppose the bill with any of those factors in there. We will oppose the pharmaceutical issues that are in those bills that will stop us from being able to deal with the next pandemic. And we are going to oppose the labor provisions that would drive a wedge between management and our workers. There are a lot of things in that bill we don’t like. But infrastructure, BIF as it’s called in Washington speak, needs to get across the line right away. It’s an accomplishment we can all be proud of.”

Timmons on the NAM’s Vaccine Mandates

“I am so proud of the NAM team…We had a…94% vaccine acceptance rate before we imposed the mandate, and since then…we have achieved 100%. And I am thrilled because our team cares about not only themselves and their families, but also the people that we interact with every day—our 14,000 member manufacturers across the country. It’s the responsible thing to do, and I am happy that team NAM came through.

…

“What I hear from every single CEO that we represent is that their number-one concern is their employees, the health of their employees, the health of their employees’ families and their communities…It’s become political at times, but it doesn’t need to be. The last administration through Operation Warp Speed helped develop a vaccine in just record time with all the safety protocols in place. This administration is executing the vaccinations across the country. It’s a bipartisan effort, a nonpartisan effort, I would say, to make sure that our communities are safe, that our country is safe and the world can return to normal. It’s the only way it’s going to happen—we know that.”

-NAM-

The National Association of Manufacturers is the largest manufacturing association in the United States, representing small and large manufacturers in every industrial sector and in all 50 states. Manufacturing employs more than 12.4 million men and women, contributes $2.44 trillion to the U.S. economy annually, has the largest economic multiplier of any major sector and accounts for 58% of private-sector research and development. The NAM is the powerful voice of the manufacturing community and the leading advocate for a policy agenda that helps manufacturers compete in the global economy and create jobs across the United States. For more information about the NAM or to follow us on Twitter and Facebook, please visit www.nam.org.

What does it look like when manufacturers get vaccinated? For some people across the country, it was just another day at work.

Hundreds of manufacturers nationwide have hosted vaccination events for their own employees, sometimes including family and community members as well. NAM Director of Photography David Bohrer stopped by a few of these events to capture them, while other companies sent the NAM their own pictures. Here are some of those photos—a visual tour of manufacturers’ efforts to keep America safe and healthy.

Calvert, Alabama: Steel and mining company ArcelorMittal held an on-site vaccine clinic at its plant for team members and the local community. If you look closely, you’ll see that one of these employees is holding a pin from the NAM and The Manufacturing Institute’s Yellow and Red Ribbon initiative—a symbol of vaccination that you can wear to show you’ve done your part.

Fremont, California: Below, an employee of ALOM Technologies Corporation, which creates supply chain technology and solutions, gets his shot at the company’s facility. In the background, you can see a poster for This Is Our Shot, the NAM and MI’s effort to help manufacturers across the country get vaccinated.

Perryville, Missouri: More than 150 Gilster-Mary Lee Corporation employees were vaccinated at an on-site clinic set up at the company’s request by the local Perry County Health Department.

In our interview with Gilster-Mary Lee President and CEO Tom Welge back in April, he told us how the tragic death of his father (and former Gilster-Mary Lee CEO) Don Welge from COVID-19 reinforced the company’s commitment to vaccinations. Read more about the company’s efforts here.

Baltimore, Maryland: Marlin Steel Wire Products led a coalition of 81 manufacturing companies in an effort to get vaccine doses for their workers. In the end, the coalition organized 17 events for more than 3,300 employees.

Here’s a photo from a March event for workers from Marlin Steel, Orlando Products and Arnold Packaging. It was hosted at Orlando’s facility, where a team from Safeway administered the shots.

We spoke to Marlin President and Owner Drew Greenblatt back in April about how he organized this effort. Check out the interview here.

 Lafayette, Indiana: At Subaru of Indiana, more than 2,900 vaccinations were delivered across eight clinics held in the facility’s lobby. The clinic was open to all on-site personnel, including vendor and contractor representatives, along with associates’ spouses and eligible kids. Recently, the company transitioned to hosting a weekly vaccine clinic at its on-site Health and Wellness Center.

Join in: If you’re a manufacturer looking to encourage vaccinations among your employees or even host an event yourself, check out the many resources available through the NAM and the MI’s This Is Our Shot project. The most recent addition is an “on-site vaccination clinic toolkit” provided by the Department of Health and Human Services. And don’t forget to wear your yellow and red ribbon pin!

As India struggles with COVID-19, manufacturers across the United States have stepped up to offer assistance and material aid.

The situation: India is grappling with a dangerous and extremely transmissible form of COVID-19, even as the country has struggled to inoculate large swaths of its population. As a result, hospitals across the country are straining to fulfill critical needs, and the situation has become dire.

The support: Many manufacturers have announced that they will provide critical assistance to response efforts in India, including the following:

• Raytheon Technologies donated four mobile oxygen trucks, working with the Indian Red Cross to get them to Delhi.
• Deere donated $2.7 million to provide urgent medical resources and health care infrastructure, working with United Way Mumbai.
• Pfizer sent $70 million worth of COVID-19 treatment medicines directly to India/Indian government to help fight the disease.
• Lilly donated 400,000 tablets of key medicine used to treat severe COVID-19 patients—and made new voluntary agreements to ramp up local manufacturing and distribution in India.
• UPS donated $1 million to India to fight COVID-19.
• FedEx is donating critical supplies to India and has donated $4 million to help nonprofit organizations reach underserved communities get COVID-19 vaccines.
• Samsung is importing 1 million Low Dead Space (LDS) syringes, which minimize the amount of drug left in the syringes after an injection.
• Boeing created a $10 million emergency assistance package for India to support the country’s response to the recent surge in COVID-19 cases.
• LyondellBasell is donating $100,000 to the U.S. India Friendship Alliance to help the organization provide 250 oxygen concentrators to India’s hospitals and medical facilities.

In related news, the United States will donate 500 million doses of Pfizer’s COVID-19 vaccine to the world, according to Reuters (subscription). The donations will be distributed this year and over the first half of next year to 92 lower-income countries and the African Union, via the COVAX vaccine program spearheaded by the World Health Organization and the Global Alliance for Vaccines and Immunization. The White House has also pledged additional direct aid to India, which is detailed here.

• The NAM has praised these efforts to accelerate vaccinations in India and the rest of the world, calling them a “powerful, effective way to improve vaccine access,” while preserving critical IP protections that made that innovation possible.

What we’re saying: “Manufacturers are deeply committed to the fight against COVID-19 in our communities, including here in the United States, in India and around the world,” said NAM Director of International Business Policy Ryan Ong. “The NAM is working directly with members and with partners like Good360 and SBP to provide critical relief where it is mostly badly needed and to help us all respond and recover from COVID-19 as we work toward a better post-pandemic world.”

Now that all American adults are eligible for vaccination and largely have easy access to vaccines, it’s even more important to convince those still on the fence about getting their shots. To help manufacturers convince their hesitating employees, The Manufacturing Institute has partnered, as a part of the “This Is Our Shot” project, with the Center for Public Interest Communications at the University of Florida on a research study about hesitancy and how manufacturers can overcome it.

The big idea: The study aimed to identify strategies that manufacturers can use to increase vaccine confidence among their teams, according to Matt Sheehan and Annie Neimand, managing director and research director, respectively, at the Center. It took a wide-ranging approach, applying social science to this public health problem and looking for evidence-based strategies that employers could put into practice right away.

Why it matters: According to the team, vaccine hesitancy can be driven by a range of factors, including a lack of access to vaccination opportunities, uncertainty about the process of getting inoculated or incorrect or confusing information. Those different motivations can be countered by different approaches, the researchers advise. Understanding where people are coming from makes it easier to give them the support they need.

What we learned: The study arrived at five steps that will help encourage manufacturing workers to get vaccinated:

• Communicate from a place of trust. To be effective, manufacturing leaders should communicate frequently and transparently about vaccination policies and vaccination rates within the facility. Vaccination goals, too, should be focused on the facility.

• Help remove barriers to getting the vaccine. Employers should make it easy to obtain the vaccine and make employees feel supported in their decision to get it. That may mean communicating in languages that their workforce uses, helping employees make vaccination appointments as needed and offering time off for employees to recover if they have significant side effects after the vaccine.

• Highlight trusted messengers. Lots of vaccine skeptics are also skeptical of outsiders, so employers should enlist trusted local authorities, civic leaders and peer influencers to disseminate information.

• Customize tactics to appeal to the community. There is no one-size-fits-all message, and it’s important to reach people who come from different backgrounds and have different ideologies. For some people, it’s important to talk about reaching herd immunity or protecting the most vulnerable in our communities. For others, it’s more effective to talk about the vaccines’ role in protecting their own families and loved ones, or even themselves.

• Address fears at an individual level. Reacting to hesitancy with negativity, or suggesting that all people who are concerned about vaccines are the same, will only increase hesitancy. Instead, listen to individual concerns, and guide people to a useful solution.

Point of emphasis: “It’s important that we listen more than we talk,” said Sheehan. “That’s what’s going to get us to the point where we reach some of these hesitant groups. We need to help solve problems rather than impart information…. If we can listen and hear and alleviate concerns and fix barriers, we’re going to see much more success.”

What’s next: The MI and the Center for Public Interest Communications are preparing to release additional research findings and a new communications guide later this month, to bolster manufacturers’ efforts to get the remainder of their teams and communities vaccinated. Stay up to date on all the latest “This Is Our Shot” project resources at NAM.org/ThisIsOurShot.